Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full dose with fewer side effects, according to a new study.
Nov 24, 2023
0
47
Psychedelic microdosing involves consuming relatively small amounts of serotonergic compounds, approximating the perceptual threshold—typically, 10–20% of a full dose. Serotonergic psychedelics are being studied as novel ...
Sep 26, 2022
0
4
A dosing error made during an AstraZeneca-University of Oxford COVID-19 vaccine trial has led to a new dosage finding in mice, reports a new Northwestern Medicine study.
Oct 25, 2021
0
131
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half ...
Dec 8, 2020
0
30
Hopes of an effective vaccine against coronavirus becoming available rose again on Monday with AstraZeneca and Oxford University claiming success with their product, becoming the third team to do so.
Nov 23, 2020
0
0
Evidence suggesting an initial half dose of the vaccine being developed by drugs firm AstraZeneca and the University of Oxford is more effective than a full dose is counterintuitive, and even took the researchers by surprise.
Nov 23, 2020
0
9
Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx ...
Jan 30, 2020
0
3
Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second-line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published ...
May 21, 2019
0
7
